Global Tech Reporter
SEE OTHER BRANDS

Get your daily news on science and technology

Global Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.

Press releases published on July 9, 2025

OrangeKloud signs Contract for the Supply and Implementation of Cloud Workspace Terminals

OrangeKloud signs Contract for the Supply and Implementation of Cloud Workspace Terminals

SINGAPORE, July 09, 2025 (GLOBE NEWSWIRE) -- OrangeKloud Technology Inc. (Nasdaq: ORKT) (“OrangeKloud” or “the Company”), a Singapore-based technology company offering the eMOBIQ® No-Code platform for development of mobile applications, is pleased to …

Immuneering Granted U.S. Composition of Matter Patent for Highly Differentiated Cancer Drug Candidate Atebimetinib

Immuneering Granted U.S. Composition of Matter Patent for Highly Differentiated Cancer Drug Candidate Atebimetinib

- Newly issued U.S. composition of matter patent expected to provide exclusivity into 2042, with subsequent opportunity for patent term extension - - First U.S. patent granted on a deep cyclic inhibitor: a once-daily pill that aims to drive longer-lasting …

KULR Reaches 750 PH/s in Bitcoin Mining Operations with Latest Deployment, Aims for 1.25 EH/s by Late Summer

KULR Reaches 750 PH/s in Bitcoin Mining Operations with Latest Deployment, Aims for 1.25 EH/s by Late Summer

HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a Bitcoin First Company and global leader in sustainable energy management, today announced the successful deployment of 3,570 Bitmain …

Layer Raises $6.6M Led by Emergence Capital to Bring Embedded Accounting to the SMB Software Stack

Layer Raises $6.6M Led by Emergence Capital to Bring Embedded Accounting to the SMB Software Stack

SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- Layer, the leading embedded accounting platform for small and medium-size business (SMB) software, today announced it has raised $6.6 million in seed funding led by Emergence Capital, with participation from …

Sonoro Gold PROVIDES AN UPDATE ON THE ENVIRONMENTAL PERMIT (mia)   FOR THE CERRO CALICHE GOLD PROJECT

Sonoro Gold PROVIDES AN UPDATE ON THE ENVIRONMENTAL PERMIT (mia) FOR THE CERRO CALICHE GOLD PROJECT

VANCOUVER, Canada, July 09, 2025 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to provide an update on the status of the Environmental Impact Statement, or Manifestacion de Impacto …

Finding certainty in market turmoil: Why more and more investors choose SAVVY MINING

Finding certainty in market turmoil: Why more and more investors choose SAVVY MINING

London, UK, July 09, 2025 (GLOBE NEWSWIRE) -- With Solana (SOL) continuing to expand in the blockchain field, Ripple (XRP) being widely used in cross-border payments in Asia, and Dogecoin (DOGE) regaining the attention of retail investors, the enthusiasm …

Upwork Research Reveals New Insights Into the AI-Human Work Dynamic

Upwork Research Reveals New Insights Into the AI-Human Work Dynamic

PALO ALTO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world’s work marketplace, today released a study by the Upwork Research Institute revealing that AI is not just accelerating productivity, but also moving from being a …

Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity

-- Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reductions in bivamelagon trial were consistent with BMI …

TopFX Expands Asset Offerings with Synthetic Indices Access

TopFX Expands Asset Offerings with Synthetic Indices Access

Mahé, Seychelles, July 09, 2025 (GLOBE NEWSWIRE) -- TopFX has now made synthetic indices trading available to all clients through its cTrader platform, marking a turning point for those who prefer structure, speed, and simplicity in the markets. This new …

Sunny Mining launches DOGE/BTC short-term contracts, with weekly new user registrations increasing by 500%

Sunny Mining launches DOGE/BTC short-term contracts, with weekly new user registrations increasing by 500%

Los Angeles, California, July 09, 2025 (GLOBE NEWSWIRE) -- GlobeNewswire Sunny Mining, a global frontrunner in crypto cloud mining, with a new series of short-term DOGE and BTC cloud mining contracts, has launched these contracts which are secured with …

Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium

Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium

SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, …

In-Camera Visual Effects (ICVFX) Market Poised to Reach USD 1.78 Billion by 2032, Accelerating at a Robust CAGR of 12.99%: AnalystView Market Insights

In-Camera Visual Effects (ICVFX) Market Poised to Reach USD 1.78 Billion by 2032, Accelerating at a Robust CAGR of 12.99%: AnalystView Market Insights

San Francisco, USA, July 09, 2025 (GLOBE NEWSWIRE) -- The global In-camera Visual Effects (ICVFX) Market is poised for substantial expansion, with projections indicating a compound annual growth rate (CAGR) of 12.99%, pushing the market value to …

Atsena Therapeutics Announces Alignment with FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)

Atsena Therapeutics Announces Alignment with FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)

Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides clear regulatory pathway to approval in a continuous Phase 1 / 2 / 3 study, avoiding the requirement for an additional registrational study and accelerating time to potential …

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

[IMAGES BELOW] Complete resolution maintained at 6 months in first patient treated with BriaCell’s Bria-OTS in Phase 1/2a study No treatment limited toxicities observed Patient remains on study with stable disease elsewhere PHILADELPHIA and VANCOUVER, …

Theratechnologies Reports Financial Results for the Second Quarter 2025

Theratechnologies Reports Financial Results for the Second Quarter 2025

Q2 2025 total revenue of $17.7 million, and $36.8 million for the first six months of Fiscal 2025 Positive Adjusted EBITDA1 for the fifth straight quarter Subsequent to quarter end, Theratechnologies entered into a definitive agreement to be acquired by an …

Theratechnologies présente ses résultats financiers pour le deuxième trimestre de 2025

Theratechnologies présente ses résultats financiers pour le deuxième trimestre de 2025

Les revenus totaux s’élèvent à 17,7 millions de dollars pour le deuxième trimestre de 2025 et à 36,8 millions de dollars pour le premier semestre de l’exercice 2025 Un BAIIA ajusté1 positif a été dégagé pour un cinquième trimestre consécutif Après la …

Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)

Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)

REDWOOD CITY, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced that the abstract titled …

NextGen Digital Announces Private Placement of Special Warrants Convertible into Secured Digital Asset-Backed Notes

NextGen Digital Announces Private Placement of Special Warrants Convertible into Secured Digital Asset-Backed Notes

Vancouver, B.C., July 09, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) is pleased to announce that it has entered into a term sheet with an arm’s-length purchaser (the “Purchaser”) …

Amerigo Reports Q2-2025 Operational Results

Amerigo Reports Q2-2025 Operational Results

Q2-2025 copper production of 15.5 million pounds 2025 production and cash cost1 guidance remain in place $7.6 million returned through Share Buybacks and Dividends in Q2-2025 VANCOUVER, British Columbia, July 09, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources …

Class 1 Nickel Commences 2025 Exploration Program at the River Valley PGE-Cu-Ni Project, Ontario, Canada

Class 1 Nickel Commences 2025 Exploration Program at the River Valley PGE-Cu-Ni Project, Ontario, Canada

TORONTO, July 09, 2025 (GLOBE NEWSWIRE) -- Class 1 Nickel and Technologies Limited (CSE: NICO | OTCQB: NICLF) ("Class 1” or the "Company") is pleased to announce the launch of its 2025 summer exploration program on its 100%-owned River Valley PGE-Cu-Ni …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions